News Digest / Ticker: AMGN

Ticker: AMGN

07:25am, Monday, Aug 25, 2025
Royalty Pharma (RPRX) buys up to $950M royalty stake in Amgen's (AMGN) KRAS G12C lung‑cancer drug sotorasib (Lumakras), converting future sales into cash - a bet on trials, label expansion and pricing.